| EPIC | SCLP |
| Sector | Pharma and Biotech |
| ISIN | GB00B63D3314 |
| Market Sector | AIM |
| Market Segment | ASQ1 |
| Main Indices | FTSE AIM All-Share |
| Country of register | Great Britain |
| Currency | British Pound |
| Market Cap | £132.32m |
| NMS | 20,000 |
| Shares in issue | 1,037.78m |
| Date Listed | 30-Jul-2010 |
| Currency | UK Pounds |
| Share Price | 12.75p |
| Change Today | 0.25p |
| % Change | 2.00 % |
| 52 Week High | 13.83p |
| 52 Week Low | 8.25p |
| Volume | 1,040,026 |
| Shares Issued | 1,037.78m |
| Market Cap | £132.32m |
| Value | ![]() |
|---|
| Price Trend |
|
|---|
| Income | ![]() |
|---|
| Growth | ![]() |
|---|
| Strong Buy | 1 |
| Buy | 2 |
| Neutral | 0 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 3 |

| No dividends found |
| Time | Volume / Share Price |
| 16:28 | 39,309 @ 12.72p |
| 15:52 | 10,000 @ 13.00p |
| 15:33 | 5,000 @ 12.70p |
| 15:27 | 57 @ 12.94p |
| 15:22 | 50,000 @ 12.94p |
| CFO | Sath Nirmalananthan |
| CEO | Phil L'Huillier |
You are here: research